Sector: Life Sciences

Latest content

Specialist Chapter: Trends and Strategies in Global Pharma and Biotech Patent Litigation

Featured in The Patent Litigation Review 2024

International patent protection is now part-and-parcel for any significant drug or therapeutic, and, as a result, disputes over patent ownership and infringement now regularly implicate a myriad of related laws across international venues. In recent years, there has been a trend towards more complex and high-stakes global patent disputes in the pharmaceutical industry, including parallel litigation across multiple jurisdictions.

29 January 2024

Owkin

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Royalty Pharma

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Roivant Sciences

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Apollo Therapeutics

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Nimbus Therapeutics

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Supreme People’s Court offers much-needed guidance following high-profile monopoly dispute involving pharma patents

In a 2023 landmark life sciences ruling, the Supreme People’s IP Court overturned the first-instance judgment – a decision that is having lasting effects on the Chinese IP landscape when it comes to assessing monopolies that involve patents.

24 January 2024

J&J’s innovative enforcement strategy confronted by antitrust challenge

Assertion of patent obtained in $6.5 billion deal was anti-competitive, says lawsuit

22 January 2024

Ravgen notches up another David-v-Goliath victory with $57 million damages award

But the outcome is bitter-sweet for the SME, which has faced many obstacles in its quest to enforce its foundational patents

18 January 2024

US patent cases plummet by 18% in 2023

The disappearance of prolific NPEs drove filings down while trends in Delaware and the Western District of Texas have catapulted EDTX Chief Judge Rodney Gilstrap back to the top

15 January 2024

Unlock unlimited access to all IAM content